Report post

How do I contact Celldex Therapeutics?

(508) 742-4300 160 Gould Street Suite 202 Needham, MA 02494 (781) 433-0771 ©2024 Celldex Therapeutics. All Rights Reserved. Privacy Policy Research Conflicts of Interest Policy Terms of Use Site Map Celldex is developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate.

Who owns Celldex?

Celldex, founded in 2004 as a subsidiary of Medarex (Medarex is now a wholly-owned subsidiary of Bristol Myers Squibb), was initially spun out as an independent private company in October 2005 with the asset acquisition of CDX-110 from Alteris Therapeutics, Inc. and the acquisition of Lorantis Limited (Cambridge, UK).

What autoimmune diseases does Celldex treat?

Inflammatory/autoimmune Inflammatory/autoimmuneInflammatory/autoimmune Therapeutic Areas Inflammation Celldex is currently developing antibody therapies for diseases with mast cell involvement, including chronic allergic/inflammatory disorders and autoimmune diseases.

The World's Leading Crypto Trading Platform

Get my welcome gifts